Description: Beijing Konruns Pharmaceutical Co.,Ltd. engages in the research and development, production, and marketing of special drugs in China. The company offers agkistrodon acutus hemocoagulase under Suling trade name in the hemagglutinin preparation market used to reduce bleeding during surgery and control postoperative surgery. It is also involved in the development of drug candidates, including CX1026, CX1003, and KC1036. Beijing Konruns Pharmaceutical Co.,Ltd. was founded in 2003 and is headquartered in Beijing, China.
Home Page: www.konruns.cn
Building 3
Beijing,
102206
China
Phone:
86 10 8289 8888
Officers
| Name | Title |
|---|---|
| Mr. Jianhua Liu | GM & Director |
Exchange: SHG
Country: CN
Currency: Renminbi (¥)
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 35.2703 |
| Price-to-Book MRQ: | 1.4754 |
| Price-to-Sales TTM: | 5.488 |
| IPO Date: | |
| Fiscal Year End: | December |
| Full Time Employees: | 473 |